Proteorex Therapeutics is Biotechnology in Canada that focus on provider business. Founded in 2014. They cover business area such as provider, oncology drug, protein-protein interaction, ppi, chemical molecule peptide, its proprietary biotechnology platform, physician, researcher, previously undruggable target.
2014
( 10 years old in 2024 )
Provider
-
MaRS West Tower
661 University Avenue, Suite 1300
Toronto, Ontario M5G 0B7
Canada
Private
provideroncology drugprotein-protein interactionppichemical molecule peptideits proprietary biotechnology platformphysicianresearcherpreviously undruggable target
* We use standard office opening hours in near Proteorex Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Proteorex Therapeutics is Biotechnology business from Canada that founded in 2014 (10 years old in 2024), Proteorex Therapeutics business is focusing on Provider.
Proteorex Therapeutics headquarter office and corporate office address is located in MaRS West Tower 661 University Avenue, Suite 1300 Toronto, Ontario M5G 0B7 Canada.
Proteorex Therapeutics was founded in Canada.
In 2024, Proteorex Therapeutics is currently focus on provider sector.
Above is snippet of Google Trends for "provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Proteorex Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
